Contrary to the subgroup analysis, postmortem human studies on diabetes with AD pathology have shown that the cerebral load of tau-related NFTs are either lower (Ahtiluoto et al., 2010) or similar (Thambisetty et al., 2013) between diabetic individuals and nondiabetic ones. Here, MAPT is linked to Alzheimer disease.